OpenVSafe by OpenVAERS
Search V-safe

N3M-11560-50768

3 vaccinations 1 coded response 6 check-ins 0 free-text entries 0 call cases
Sex
Female
Age at first dose
0-4
ZIP prefix
483 / MI
Registered
2022-08-10
Relationship
Child or adolescent in my care
Guardian
C4K-22319-72985
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-08-10
    Registered in v-safe
  2. 2022-08-31
    Dose 1 — Pfizer-BioNTech
  3. 2022-09-01
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-09-02
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-09-05
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-09-21
    Dose 2 — Pfizer-BioNTech
  7. 2023-01-27
    Dose 3 — Pfizer-BioNTech
  8. 2023-01-31
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2023-02-01
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2023-02-03
    Survey response — day 7, dose 3, under 3
    MedDRA: Nasopharyngitis — Feeling: Fair · Fever
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12022-08-31Pfizer-BioNTech No
22022-09-21Pfizer-BioNTech No
32023-01-27Pfizer-BioNTech No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SRONasopharyngitis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…